| US 7,591,801 B2 | ||
| Integrated delivery device for continuous glucose sensor | ||
| James H. Brauker, San Diego, Calif. (US); Mark A. Tapsak, San Diego, Calif. (US); Sean T. Saint, San Diego, Calif. (US); Apurv U. Kamath, Solana Beach, Calif. (US); Paul V. Neale, San Diego, Calif. (US); Peter C. Simpson, Del Mar, Calif. (US); Michael Robert Mensinger, San Diego, Calif. (US); and Dubravka Markovic, San Diego, Calif. (US) | ||
| Assigned to Dexcom, Inc., San Diego, Calif. (US) | ||
| Filed on Feb. 26, 2004, as Appl. No. 10/789,359. | ||
| Prior Publication US 2005/0192557 A1, Sep. 01, 2005 | ||
| Int. Cl. A61M 37/00 (2006.01) | ||
| U.S. Cl. 604—161 [604/65] | 37 Claims |
| 1. An integrated system for monitoring and treating diabetes, the system comprising:
a glucose sensor, wherein the glucose sensor substantially continuously measures glucose in a host for a period exceeding
one hour, and outputs a data stream, including one or more sensor data points;
a receiver operably connected to the glucose sensor, wherein the receiver is configured to receive the data stream; and
a medicament delivery device, wherein the delivery device is physically detachably connectable to the receiver, wherein at
least one of the receiver and the medicament delivery device comprises programming that automatically detects impending clinical
risk and calculates a therapy recommendation responsive to the impending clinical risk, and wherein the at least one of the
receiver and the medicament delivery device further comprises programming that requires the at least one of the receiver and
the medicament delivery device to be at least one of validated and confirmed by a user interaction in response to a prompt
on the user interface.
|